2 results
Approved WMOCompleted
Part 1To evaluate the safety, tolerability, and pharmacokinetics (PK) of multiple intravenous doses of FEP-TAZ 4 g (2 g cefepime + 2 g tazobactam) and FEP-TAZ 3 g (2 g cefepime + 1 g tazobactam) administered every 8 hours (q8h) in healthy adult…
Approved WMORecruiting
• Assessment of clinical, radiographic and subjective outcomes after anatomic or reverse shoulder arthroplasty with SMR stemless prosthesis;• Survival analysis;• Incidence of adverse events and identification of possible risk factors for failure.